May 20, 2022 HAS gave a favorable opinion for Xeljanz in patients with polyarticular juvenile idiopathic arthritis HAS given position...

May 25, 2022 Keytruda was recommended for a rare form of TNBC NICE has published the final draft recommendation, in which Keytruda...

May 20, 2022 FDA approved Dupixent for patients with eosinophilic esophagitis Sanofi announced that the US FDA approved Dupixent...

May 10, 2022 Pfizer will acquire Biohaven Pharmaceuticals. Pfizer and Biohaven Pharmaceuticals announced that they had entered an...

April 29, 2022 Evrysdi improved survival and motor milestones in infants with type 1 SMA Roche announced that Evrysdi (risdiplam)...

REVENUES OF TOP BIOPHARMACEUTICAL COMPANIES 2022 1 CHF = 1.04 USD Merck revenues include only pharmaceuticals (excluding animal health)...

EXPECTED BEST SELLING PRODUCTS OF 2022 Comirnaty (Pfizer) Comirnaty is a messenger RNA (mRNA) based COVID vaccine developed by Pfizer and...

April 15, 2022 Tislelizumab was approved in China as second-line therapy for esophageal squamous cell carcinoma BeiGene announced that...

Health Canada approved Rybrevant for EGFR exon insertion mutation NSCLC. Janssen announced that Health Canada issued a Notice of...

TOP BIOPHARMACEUTICAL COMPANIES BY REVENUES IN 2021 Revenues in billions Also read: Italy healthcare system 1. JOHNSON AND JOHNSON Q1...

Feb 23, 2022 Moderna's Spikevax received provisional approval for individuals aged six years and older The Therapeutic Goods...

Jan 18, 2022 Merck and Ridgeback to supply 3 million courses of molnupiravir to UNICEF Merck and Ridgeback Biotherapeutics announced that...

Exscientia and Sanofi collaborated to develop AI-driven pipeline medicines, UK based drug discovery companies may receive payments up to...

Jan 14, 2022 EMA asked to add another adverse event to the label of Vaxzevria and Janssen COVID19 vaccine EMA asked to change the label...

India started vaccination of adolescents; Bharat Biotech says Covaxin demonstrated robust efficacy and safety in people of age 2-18 years...

PHARMACEUTICAL COMPANIES BY REVENUES IN 202O Also check: Top pharmaceutical companies by revenues in 2021 The other big biopharmaceutical...

Janssen announced that it had submitted a biologics license application of teclistamab to the US FDA for relapsed or refractory multiple...

Pfizer has announced that the Food and Drug Administration approved Paxlovid (nirmatrelvir tablets and ritonavir tablets) to treat...

Novartis announced that the US FDA approved Leqvio (inclisiran) to decrease the lower low-density lipoprotein cholesterol (bad...

FDA approved Vyvgart for Myasthenia Gravis FDA announced that it had approved Vyvgart (efgartigimod) for generalized myasthenia gravis...

Viiv's Apretude approved in the US for HIV prevention ViiV, an HIV-specialized company owned by GSK, Pfizer, and Shionogi, announced that...

December 2021 IQWIG says Rinvoq has added benefit at higher doses, but with safety issues IQWIG has assessed the benefit assessment of...

China has released the 2021 Drug catalog, which included 2,860 drugs, out of which 1,486 drugs are Western drugs. Reuters reported a...

21 November 2021 Australia included Takhzyro in PBS scheme Australia included Takhzyro (lanadelumab) in the Pharmaceutical Benefits...

Ronapreve (casirivimab / imdevimab) approved for treating and preventing COVID19 in adults and adolescents Celltrion's Regkirona...

ABBVIE RINVOQ AbbVie presented the Phase 3 SELECT-PsA 1 and SELECT-PsA 2 data of Rinvoq in patients with psoriatic arthritis. Rinvoq...

The U.N. agency World Health Organisation (WHO) had made a statement on the next WHO chief. WHO announced that the member states proposed...

WHO has announced that it has granted emergency use listing for Covaxin developed by Bharat Biotech. This adds another vaccine to the...

Novartis announced that the US FDA had approved Scemblix (asciminib) for treating patients with chronic myeloid leukemia. Scemblix...

The US FDA approved Biogen's Aduhelm (aducanumab) for Alzheimer's disease. It is the first approved product for AD since 2003 and acts by...

NOVARTIS Kymriah demonstrated a strong response in patients with relapsed or refractory follicular lymphoma Novartis presented the...

NHS to offer Tagrisso for lung cancer patients NHS England announced that it would roll out Tagrisso (osimertinib) for lung cancer...

As of May 9th, one-third of adults in England received two doses of the COVID19 vaccine NHS England announced that one-third of adults in...

CMS adopted new provisions to reduce the out-of-pocket cost for patients who rely on Federal Health Insurance Marketplaces The Centers...

GlaxoSmithKline announced that it received approval for expanded use of Benlysta (belimumab) for lupus nephritis in Europe. The drug is...

HAS recommended the user of mRNA vaccines for a population already administered with AstraZeneca vaccine AstraZeneca’s COVID19 vaccine...

AMGEN Otezla Otezla presented a significant improvement in the disease severity in mild-to-moderate patients, according to the Phase 3...

GSK has announced that the US FDA has approved Jemperli (dostarlimab), a programmed death receptor-1 (PD-1) for endometrial cancer. The...

Tysabri is now available as SC in Europe Biogen announced that the European Commission had approved the new subcutaneous form of Tysabri...

Gilead’s Trodelvy (sacituzumab govitecan) has announced that it has received approval from the US FDA for triple-negative breast cancer...

NHS England recommended the use of Roche's Phesgo (pertuzumab/trastuzumab) for treating HER2-positive breast cancer. HER2-positive breast...

March 2021 CHMP Positive Opinion Verastem’s Copiktra (duvelisib) received CHMP positive opinion for treating CLL and FL CHMP gave a...

Australia prefers Pfizer vaccine, US agency raises concerns over the information released by AstraZeneca, EMA’s safety committee says the...

Bristol Myers Squibb and bluebird bio, Inc. announced that the US Food and Drug Administration approved Abecma (idecabtagene vicleucel;...

The US FDA announced that it will hold a meeting of the Oncologic Drugs Advisory Committee on April 27-29 to review six indications...

Mar 12. 2021 Takeda’s New Drug Application was submitted for MHLW in Japan for Hereditary Angioedema Attacks Takeda announced that it...

03 May 2019 TGA approved Yondelis for liposarcoma TGA approved the new chemical entity, Yondelis (trabectedin), for treating patients...

US FDA approved Janssen’s Ponvory for multiple sclerosis Janssen announced that the US FDA approved Ponvory (ponesimod) for treating...

Novartis has received the US FDA approval of Entresto ((sacubitril/valsartan) for the broader target population; it is now approved for...